Evidently, the overall survival of glioma patients can be affected by many important clinical and genetic factors, such as age, tumor grades, ATRX status, IDH1/2 status, telomerase reverse transcriptase (TERT) status, and so on16,17. The gene discussed is ATRX; the disease is neoplasm.